Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study
- 8 December 2012
- journal article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 51 (4) , 889-895
Abstract
Background: Cancer biomarkers (CBs) can be used in early detection of several cancers as well as in detection of recurrence and following response to treatment. We aimed to investigate the levels of CBs in proteinuric patients with primary glomerular disease (PGD) and diabetes mellitus, and compare them with healthy controls. Methods: One hundred and two patients with untreated PGD, 62 proteinuric patients with diabetic nephropathy, and 84 healthy controls were enrolled. Levels of cancer antigen 125 (CA 125), cancer antigen 15–3 (CA 15–3), carcinoembriogenic antigen (CEA), α-fetoprotein (AFP), total prostate specific antigen (TPSA), free prostate specific antigen (FPSA) and carbohydrate antigen 19–9 (CA 19–9) were measured. Results: Compared to healthy controls, levels of CA 125, CA 15–3 and CA 19–9 were higher in patients with PGD and diabetic patients (all pConclusions: CBs levels seem to be changed in different proteinuric patients. This condition should be kept in mind when evaluating CBs levels in proteinuric patients.Keywords
This publication has 17 references indexed in Scilit:
- CA 19-9 Level in Patients With Type 2 Diabetes Mellitus and Its Relation to the Metabolic Control and Microvascular ComplicationsThe American Journal of the Medical Sciences, 2011
- Coagulopathy in a patient with nephrotic syndromeAmerican Journal of Hematology, 2010
- Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: Associations with organ manifestations, immunolaboratory markers and disease activity indicesJournal of Autoimmunity, 2008
- Properties of the Glomerular Barrier and Mechanisms of ProteinuriaPhysiological Reviews, 2008
- Benign causes of increased serum CA-125 concentrationThe Lancet Oncology, 2007
- The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitisInternational Urology and Nephrology, 2006
- SERUM TUMOR MARKERS AFTER RENAL TRANSPLANTATIONTransplantation, 1996
- Tumor Markers in Chronic Renal Failure and Hemodialysis PatientsNephron, 1991
- Metabolism of Albumin and Immunoglobulins in the Nephrotic SyndromeAmerican Journal of Nephrology, 1990
- Serum Carcinoembryonic Antigen (CEA) in Patients with Chronic Inflammatory Bowel DiseaseDigestion, 1973